$4.02
Today
as of Jul 22, 16:52 ET
Last 30 days
Recent Press Releases & News
Lifeward Enters Securities Purchase Agreement Under Oramed Financing Framework
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
ORMP: View Inclusion in Russell Indexes as Positive That Could Raise Awareness in Investment Community
Overview
52-week range
$1.98
$5.01
67% of range
Avg surprise (last 2)
-279.2%
Avg reaction (last 2)
+0.2%
50% positive
Latest IV / EM
83%
EM ±13.0% · $5 · Jul 17
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 19, 2026 | Mar/2026 | $-0.16 | — | — | +15.8% | +0.9% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $1.13 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-0.05 | $-0.04 | -25.0% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.19 | $-0.03 | -533.3% | — | -0.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.48 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.22 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.04 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.08 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.03 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | OTHER | $0.43 | -$0.05 | +960.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $2M | — | — | — |
| Cost of revenue | — | — | — | — | $2M | — | — | — |
| Gross profit | — | — | — | — | $13,000 | — | — | — |
| Operating income | $-4M | — | $-2M | $-2M | $-4M | — | $-3M | $-3M |
| Net income | $38M | — | $48M | $13M | $-8M | — | $-20M | $9M |
| EPS (diluted) | $0.91 | — | $1.13 | $0.31 | $-0.19 | — | $-0.48 | $0.22 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $13M | $46M | $52M | $16M | — | $54M | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $68M | $133M | $136M | $99M | $131M | $143M | $143M | $153M |
| Total assets | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | — | — | $203M | $155M | $141M | $146M | $156M | $177M |